Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × trifluridine tipiracil drug combination × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 21 Rectal Neoplasms 6 Colonic Neoplasms 6 Stomach Neoplasms 3 Advanced Solid Tumors 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Pancreatic Neoplasms 2 Colorectal Cancer Metastatic 2 mCRC 1 Spinocerebellar Degenerations 1 Neutropenia 1 Neoplasm Metastasis 1 Microsatellite-stable Colorectal Cancer 1 High-grade Extra Pulmonary Neuroendocrine Cancer 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Gastric and Gastroesophageal Junction Adenocarcinoma 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 ESCC 1 EFS 1 Dihydropyrimidine Dehydrogenase Deficiency 1 Digestive System Diseases 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Anal Cancer Metastatic 1 Advanced/Metastatic Solid Tumors 1

Interventions

Nivolumab 63 pembrolizumab 62 cabozantinib 43 Ipilimumab 33 Magnetic Resonance Spectroscopy 30 Specimen Handling 26 lenvatinib 21 Axitinib 20 belzutifan 16 Sunitinib 16 Radiosurgery 13 Biopsy 13 atezolizumab 10 Everolimus 10 CTLA-4 Antigen 10 pazopanib 9 avelumab 8 Radiotherapy 8 Bevacizumab 8 fludarabine 6 cemiplimab 6 aldesleukin 6 Standard of Care 6 Nephrectomy 6 Immunoglobulin G 6 Cyclophosphamide 6 toripalimab 5 spartalizumab 5 Paclitaxel 5 tivozanib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡